We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
How is Teladoc Health Placed in the Growing Telemedicine Market?
Read MoreHide Full Article
Key Takeaways
Teladoc is positioned to benefit from growing telemedicine demand driven by expanded Medicare coverage.
The Microsoft partnership enhances Teladoc's Solo platform with AI for better documentation and care quality.
TDOC's investments in technology and network expansion aim to boost its role in global virtual healthcare.
Teladoc Health (TDOC - Free Report) , a leading global provider of virtual healthcare, is well-positioned to capitalize on the evolving dynamics of the telemedicine market. Telemedicine is revolutionizing healthcare access, supported by regulatory measures such as the 1135 waiver and the Coronavirus Preparedness Act, which expanded Medicare coverage for telehealth visits across offices, hospitals, and patients’ homes. This growing demand for remote medical services continues to accelerate the adoption of telehealth solutions, directly benefiting industry leader Teladoc.
In July 2023, Teladoc strengthened its technological edge by extending its partnership with Microsoft to integrate advanced AI into its Solo platform. This collaboration aims to automate clinical documentation during virtual consultations while enhancing care quality. With an estimated U.S. total addressable market of $261 billion, Teladoc’s comprehensive offerings position it to capture substantial market share.
According to a Towards Healthcare report, the U.S. telehealth market, valued at $42.61 billion in 2024, is projected to rise to $52.76 billion in 2025 and reach $358.96 billion by 2034. Teladoc’s broad suite of integrated services—spanning non-urgent consultations to complex chronic-care management—enables it to serve diverse patient needs and fully leverage this expansion.
Although the company continues to incur losses due to heavy investments in client acquisition, provider network development, and technology innovation, these expenditures strengthen its competitive position. As the most comprehensive player in virtual care, Teladoc aims to become the primary “front door” to the healthcare system for millions of members worldwide.
What About TDOC’s Peers?
HCA Healthcare (HCA - Free Report) and CVS Health Corporation (CVS - Free Report) are well-positioned to capitalize on the rapid growth of the telemedicine market. HCA Healthcare is integrating virtual care across its extensive network of hospitals and physicians, improving accessibility and continuity of treatment for patients. Meanwhile, CVS Health leverages its MinuteClinic and Virtual Care services to merge telehealth with its broad retail and pharmacy footprint, delivering affordable, convenient and connected care.
Both HCA Healthcare and CVS Health continue to invest heavily in digital health infrastructure, remote monitoring and strategic partnerships, enabling them to capitalize on the opportunities in the evolving healthcare landscape.
TDOC’s Price Performance
Shares of Teladoc have lost 17.2% year to date against the industry’s increase of 3.1%.
Image Source: Zacks Investment Research
TDOC’s Expensive Valuation
TDOC is trading at a forward 12-month price-to-sales multiple of 0.53, higher than the industry average of 0.45.
Image Source: Zacks Investment Research
Estimates Movement for TDOC
The Zacks Consensus Estimate for TDOC’s fourth-quarter 2025 loss has narrowed by 1 cent, while that for the first-quarter 2026 loss has improved by 2 cents over the past 30 days. While the consensus estimate for full-year 2025 witnessed no movement, the one for 2026 loss has narrowed 3 cents in the same time frame.
Image Source: Zacks Investment Research
The consensus estimate for TDOC’s 2025 revenues indicates a year-over-year decline, but the same for 2026 suggests a year-over-year increase. The consensus estimates for 2025 and 2026 EPS indicate year-over-year increases.
Image: Shutterstock
How is Teladoc Health Placed in the Growing Telemedicine Market?
Key Takeaways
Teladoc Health (TDOC - Free Report) , a leading global provider of virtual healthcare, is well-positioned to capitalize on the evolving dynamics of the telemedicine market. Telemedicine is revolutionizing healthcare access, supported by regulatory measures such as the 1135 waiver and the Coronavirus Preparedness Act, which expanded Medicare coverage for telehealth visits across offices, hospitals, and patients’ homes. This growing demand for remote medical services continues to accelerate the adoption of telehealth solutions, directly benefiting industry leader Teladoc.
In July 2023, Teladoc strengthened its technological edge by extending its partnership with Microsoft to integrate advanced AI into its Solo platform. This collaboration aims to automate clinical documentation during virtual consultations while enhancing care quality. With an estimated U.S. total addressable market of $261 billion, Teladoc’s comprehensive offerings position it to capture substantial market share.
According to a Towards Healthcare report, the U.S. telehealth market, valued at $42.61 billion in 2024, is projected to rise to $52.76 billion in 2025 and reach $358.96 billion by 2034. Teladoc’s broad suite of integrated services—spanning non-urgent consultations to complex chronic-care management—enables it to serve diverse patient needs and fully leverage this expansion.
Although the company continues to incur losses due to heavy investments in client acquisition, provider network development, and technology innovation, these expenditures strengthen its competitive position. As the most comprehensive player in virtual care, Teladoc aims to become the primary “front door” to the healthcare system for millions of members worldwide.
What About TDOC’s Peers?
HCA Healthcare (HCA - Free Report) and CVS Health Corporation (CVS - Free Report) are well-positioned to capitalize on the rapid growth of the telemedicine market.
HCA Healthcare is integrating virtual care across its extensive network of hospitals and physicians, improving accessibility and continuity of treatment for patients. Meanwhile, CVS Health leverages its MinuteClinic and Virtual Care services to merge telehealth with its broad retail and pharmacy footprint, delivering affordable, convenient and connected care.
Both HCA Healthcare and CVS Health continue to invest heavily in digital health infrastructure, remote monitoring and strategic partnerships, enabling them to capitalize on the opportunities in the evolving healthcare landscape.
TDOC’s Price Performance
Shares of Teladoc have lost 17.2% year to date against the industry’s increase of 3.1%.
Image Source: Zacks Investment Research
TDOC’s Expensive Valuation
TDOC is trading at a forward 12-month price-to-sales multiple of 0.53, higher than the industry average of 0.45.
Image Source: Zacks Investment Research
Estimates Movement for TDOC
The Zacks Consensus Estimate for TDOC’s fourth-quarter 2025 loss has narrowed by 1 cent, while that for the first-quarter 2026 loss has improved by 2 cents over the past 30 days. While the consensus estimate for full-year 2025 witnessed no movement, the one for 2026 loss has narrowed 3 cents in the same time frame.
Image Source: Zacks Investment Research
The consensus estimate for TDOC’s 2025 revenues indicates a year-over-year decline, but the same for 2026 suggests a year-over-year increase. The consensus estimates for 2025 and 2026 EPS indicate year-over-year increases.
TDOC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.